EZH2 and bladder transitional cell carcinoma: The results showed that the expression of EZH2 was up‐regulated in various tumours (liver hepatocellular carcinoma, bladder urothelial carcinoma, colon adenocarcinoma, etc) compared with normal tissues (Figure 1A).